EPSILON HEALTHCARE LIMITED
ASX:EPNPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 72.0% of what they think they own, once every option and right converts.
Runway under 2 quarters; options/rights overhang 39% of shares; 31% of shares in the money
EPSILON HEALTHCARE LIMITED increased its ordinary share count by 12.7% between December 2024 and February 2026, its latest share-count filing, to 389M shares. In that period the company conducted one capital raise, a convertible notes issue in May 2025 raising A$555K. Options and rights on issue could convert into 151M new shares, representing a 38.8% overhang of which 31% are in the money at the current share price; the nearest expiry is June 2028. The company has under 2 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 4
When did EPN last raise capital?
The last capital raise in Epsilon Healthcare's filings is Convertible Notes of $555k announced 15 May 2025, one of 1 cash raises in 24 months.
How much placement capacity does EPN have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
When do EPN's options expire?
Unexercised options and rights equal 38.8% of Epsilon Healthcare's shares on issue; the nearest expiry is June 2028.
How much has EPN's share count grown?
Epsilon Healthcare has 389.1M shares on issue as at 28 Oct 2026, up 12.7% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 9 June 2026 | 3G · unquoted | EPN : ORDINARY FULLY PAID | 389.1M | Appendix 3G |
| 11 Feb 2026 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 389.1M | Appendix 2A |
| 6 Feb 2026 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 384.1M | Appendix 2A |
| 15 Sept 2025 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 379.1M | Appendix 2A |
| 11 Sept 2025 | 3H · cancellation | EPN : ORDINARY FULLY PAID | 373.1M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.021 today, 119.0M securities are in the money (30.6% of shares on issue). No price up to ten times today’s switches on any more priced supply.
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 32.0M (21.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EPNAO | Options | Price-triggered | $0.020 | 24 June 2028 | 119.0M | Filing |
| — | Options | Price-triggered, no exercise price stated | — | 5 June 2029 | 32.0M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 10 Sept 2026 | Zoe Hutchings | Buy on-market | 358k | — | — | $10k | 3Y notice |
| 3 Sept 2026 | Alan Preston Beasley | Buy on-market | 1.2M | — | — | $29k | 3Y notice |
| 3 July 2026 | Zoe Hutchings | Buy off-market | 1.5M | — | — | $30k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.